Cargando…

Multi-Country Evaluation of the Sensitivity and Specificity of Two Commercially-Available NS1 ELISA Assays for Dengue Diagnosis

BACKGROUND: Early diagnosis of dengue can assist patient triage and management and prevent unnecessary treatments and interventions. Commercially available assays that detect the dengue virus protein NS1 in the plasma/serum of patients offers the possibility of early and rapid diagnosis. METHODOLOGY...

Descripción completa

Detalles Bibliográficos
Autores principales: Guzman, Maria G., Jaenisch, Thomas, Gaczkowski, Roger, Ty Hang, Vo Thi, Sekaran, Shamala Devi, Kroeger, Axel, Vazquez, Susana, Ruiz, Didye, Martinez, Eric, Mercado, Juan C., Balmaseda, Angel, Harris, Eva, Dimano, Efren, Leano, Prisca Susan A., Yoksan, Sutee, Villegas, Elci, Benduzu, Herminia, Villalobos, Iris, Farrar, Jeremy, Simmons, Cameron P.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2930874/
https://www.ncbi.nlm.nih.gov/pubmed/20824173
http://dx.doi.org/10.1371/journal.pntd.0000811
_version_ 1782186008309137408
author Guzman, Maria G.
Jaenisch, Thomas
Gaczkowski, Roger
Ty Hang, Vo Thi
Sekaran, Shamala Devi
Kroeger, Axel
Vazquez, Susana
Ruiz, Didye
Martinez, Eric
Mercado, Juan C.
Balmaseda, Angel
Harris, Eva
Dimano, Efren
Leano, Prisca Susan A.
Yoksan, Sutee
Villegas, Elci
Benduzu, Herminia
Villalobos, Iris
Farrar, Jeremy
Simmons, Cameron P.
author_facet Guzman, Maria G.
Jaenisch, Thomas
Gaczkowski, Roger
Ty Hang, Vo Thi
Sekaran, Shamala Devi
Kroeger, Axel
Vazquez, Susana
Ruiz, Didye
Martinez, Eric
Mercado, Juan C.
Balmaseda, Angel
Harris, Eva
Dimano, Efren
Leano, Prisca Susan A.
Yoksan, Sutee
Villegas, Elci
Benduzu, Herminia
Villalobos, Iris
Farrar, Jeremy
Simmons, Cameron P.
author_sort Guzman, Maria G.
collection PubMed
description BACKGROUND: Early diagnosis of dengue can assist patient triage and management and prevent unnecessary treatments and interventions. Commercially available assays that detect the dengue virus protein NS1 in the plasma/serum of patients offers the possibility of early and rapid diagnosis. METHODOLOGY/PRINCIPAL FINDINGS: The sensitivity and specificity of the Pan-E Dengue Early ELISA and the Platelia™ Dengue NS1 Ag assays were compared against a reference diagnosis in 1385 patients in 6 countries in Asia and the Americas. Platelia was more sensitive (66%) than Pan-E (52%) in confirmed dengue cases. Sensitivity varied by geographic region, with both assays generally being more sensitive in patients from SE Asia than the Americas. Both kits were more sensitive for specimens collected within the first few days of illness onset relative to later time points. Pan-E and Platelia were both 100% specific in febrile patients without evidence of acute dengue. In patients with other confirmed diagnoses and healthy blood donors, Platelia was more specific (100%) than Pan-E (90%). For Platelia, when either the NS1 test or the IgM test on the acute sample was positive, the sensitivity versus the reference result was 82% in samples collected in the first four days of fever. NS1 sensitivity was not associated to disease severity (DF or DHF) in the Platelia test, whereas a trend for higher sensitivity in DHF cases was seen in the Pan-E test (however combined with lower overall sensitivity). CONCLUSIONS/SIGNIFICANCE: Collectively, this multi-country study suggests that the best performing NS1 assay (Platelia) had moderate sensitivity (median 64%, range 34–76%) and high specificity (100%) for the diagnosis of dengue. The poor sensitivity of the evaluated assays in some geographical regions suggests further assessments are needed. The combination of NS1 and IgM detection in samples collected in the first few days of fever increased the overall dengue diagnostic sensitivity.
format Text
id pubmed-2930874
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-29308742010-09-03 Multi-Country Evaluation of the Sensitivity and Specificity of Two Commercially-Available NS1 ELISA Assays for Dengue Diagnosis Guzman, Maria G. Jaenisch, Thomas Gaczkowski, Roger Ty Hang, Vo Thi Sekaran, Shamala Devi Kroeger, Axel Vazquez, Susana Ruiz, Didye Martinez, Eric Mercado, Juan C. Balmaseda, Angel Harris, Eva Dimano, Efren Leano, Prisca Susan A. Yoksan, Sutee Villegas, Elci Benduzu, Herminia Villalobos, Iris Farrar, Jeremy Simmons, Cameron P. PLoS Negl Trop Dis Research Article BACKGROUND: Early diagnosis of dengue can assist patient triage and management and prevent unnecessary treatments and interventions. Commercially available assays that detect the dengue virus protein NS1 in the plasma/serum of patients offers the possibility of early and rapid diagnosis. METHODOLOGY/PRINCIPAL FINDINGS: The sensitivity and specificity of the Pan-E Dengue Early ELISA and the Platelia™ Dengue NS1 Ag assays were compared against a reference diagnosis in 1385 patients in 6 countries in Asia and the Americas. Platelia was more sensitive (66%) than Pan-E (52%) in confirmed dengue cases. Sensitivity varied by geographic region, with both assays generally being more sensitive in patients from SE Asia than the Americas. Both kits were more sensitive for specimens collected within the first few days of illness onset relative to later time points. Pan-E and Platelia were both 100% specific in febrile patients without evidence of acute dengue. In patients with other confirmed diagnoses and healthy blood donors, Platelia was more specific (100%) than Pan-E (90%). For Platelia, when either the NS1 test or the IgM test on the acute sample was positive, the sensitivity versus the reference result was 82% in samples collected in the first four days of fever. NS1 sensitivity was not associated to disease severity (DF or DHF) in the Platelia test, whereas a trend for higher sensitivity in DHF cases was seen in the Pan-E test (however combined with lower overall sensitivity). CONCLUSIONS/SIGNIFICANCE: Collectively, this multi-country study suggests that the best performing NS1 assay (Platelia) had moderate sensitivity (median 64%, range 34–76%) and high specificity (100%) for the diagnosis of dengue. The poor sensitivity of the evaluated assays in some geographical regions suggests further assessments are needed. The combination of NS1 and IgM detection in samples collected in the first few days of fever increased the overall dengue diagnostic sensitivity. Public Library of Science 2010-08-31 /pmc/articles/PMC2930874/ /pubmed/20824173 http://dx.doi.org/10.1371/journal.pntd.0000811 Text en Guzman et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Guzman, Maria G.
Jaenisch, Thomas
Gaczkowski, Roger
Ty Hang, Vo Thi
Sekaran, Shamala Devi
Kroeger, Axel
Vazquez, Susana
Ruiz, Didye
Martinez, Eric
Mercado, Juan C.
Balmaseda, Angel
Harris, Eva
Dimano, Efren
Leano, Prisca Susan A.
Yoksan, Sutee
Villegas, Elci
Benduzu, Herminia
Villalobos, Iris
Farrar, Jeremy
Simmons, Cameron P.
Multi-Country Evaluation of the Sensitivity and Specificity of Two Commercially-Available NS1 ELISA Assays for Dengue Diagnosis
title Multi-Country Evaluation of the Sensitivity and Specificity of Two Commercially-Available NS1 ELISA Assays for Dengue Diagnosis
title_full Multi-Country Evaluation of the Sensitivity and Specificity of Two Commercially-Available NS1 ELISA Assays for Dengue Diagnosis
title_fullStr Multi-Country Evaluation of the Sensitivity and Specificity of Two Commercially-Available NS1 ELISA Assays for Dengue Diagnosis
title_full_unstemmed Multi-Country Evaluation of the Sensitivity and Specificity of Two Commercially-Available NS1 ELISA Assays for Dengue Diagnosis
title_short Multi-Country Evaluation of the Sensitivity and Specificity of Two Commercially-Available NS1 ELISA Assays for Dengue Diagnosis
title_sort multi-country evaluation of the sensitivity and specificity of two commercially-available ns1 elisa assays for dengue diagnosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2930874/
https://www.ncbi.nlm.nih.gov/pubmed/20824173
http://dx.doi.org/10.1371/journal.pntd.0000811
work_keys_str_mv AT guzmanmariag multicountryevaluationofthesensitivityandspecificityoftwocommerciallyavailablens1elisaassaysfordenguediagnosis
AT jaenischthomas multicountryevaluationofthesensitivityandspecificityoftwocommerciallyavailablens1elisaassaysfordenguediagnosis
AT gaczkowskiroger multicountryevaluationofthesensitivityandspecificityoftwocommerciallyavailablens1elisaassaysfordenguediagnosis
AT tyhangvothi multicountryevaluationofthesensitivityandspecificityoftwocommerciallyavailablens1elisaassaysfordenguediagnosis
AT sekaranshamaladevi multicountryevaluationofthesensitivityandspecificityoftwocommerciallyavailablens1elisaassaysfordenguediagnosis
AT kroegeraxel multicountryevaluationofthesensitivityandspecificityoftwocommerciallyavailablens1elisaassaysfordenguediagnosis
AT vazquezsusana multicountryevaluationofthesensitivityandspecificityoftwocommerciallyavailablens1elisaassaysfordenguediagnosis
AT ruizdidye multicountryevaluationofthesensitivityandspecificityoftwocommerciallyavailablens1elisaassaysfordenguediagnosis
AT martinezeric multicountryevaluationofthesensitivityandspecificityoftwocommerciallyavailablens1elisaassaysfordenguediagnosis
AT mercadojuanc multicountryevaluationofthesensitivityandspecificityoftwocommerciallyavailablens1elisaassaysfordenguediagnosis
AT balmasedaangel multicountryevaluationofthesensitivityandspecificityoftwocommerciallyavailablens1elisaassaysfordenguediagnosis
AT harriseva multicountryevaluationofthesensitivityandspecificityoftwocommerciallyavailablens1elisaassaysfordenguediagnosis
AT dimanoefren multicountryevaluationofthesensitivityandspecificityoftwocommerciallyavailablens1elisaassaysfordenguediagnosis
AT leanopriscasusana multicountryevaluationofthesensitivityandspecificityoftwocommerciallyavailablens1elisaassaysfordenguediagnosis
AT yoksansutee multicountryevaluationofthesensitivityandspecificityoftwocommerciallyavailablens1elisaassaysfordenguediagnosis
AT villegaselci multicountryevaluationofthesensitivityandspecificityoftwocommerciallyavailablens1elisaassaysfordenguediagnosis
AT benduzuherminia multicountryevaluationofthesensitivityandspecificityoftwocommerciallyavailablens1elisaassaysfordenguediagnosis
AT villalobosiris multicountryevaluationofthesensitivityandspecificityoftwocommerciallyavailablens1elisaassaysfordenguediagnosis
AT farrarjeremy multicountryevaluationofthesensitivityandspecificityoftwocommerciallyavailablens1elisaassaysfordenguediagnosis
AT simmonscameronp multicountryevaluationofthesensitivityandspecificityoftwocommerciallyavailablens1elisaassaysfordenguediagnosis